Page last updated: 2024-08-23

lonidamine and Experimental Mammary Neoplasms

lonidamine has been researched along with Experimental Mammary Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Cesare, M; Pratesi, G; Zunino, F1

Other Studies

1 other study(ies) available for lonidamine and Experimental Mammary Neoplasms

ArticleYear
Efficacy of lonidamine combined with different DNA-damaging agents in the treatment of the MX-1 tumor xenograft.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:2

    Topics: Animals; Antineoplastic Agents; Cisplatin; Cyclophosphamide; DNA Damage; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Female; Humans; Indazoles; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasm Transplantation; Tumor Cells, Cultured

1996